NDC 70709-062

TASCENSO ODT

Fingolimod Lauryl Sulfate

TASCENSO ODT is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Cycle Pharmaceuticals Ltd. The primary component is Fingolimod Lauryl Sulfate.

• Product ID: 70709-062_4be47e90-9b9e-4090-8e17-d0188e4e120f
• NDC: 70709-062
• Product Type: Human Prescription Drug
• Proprietary Name: TASCENSO ODT
• Generic Name: Fingolimod Lauryl Sulfate
• Dosage Form: Tablet, Orally Disintegrating
• Route of Administration: ORAL
• Marketing Start Date: 2023-01-01
• Marketing Category: NDA /
• Application Number: NDA214962
• Labeler Name: Cycle Pharmaceuticals Ltd
• Substance Name: FINGOLIMOD LAURYL SULFATE
• Active Ingredient Strength: 0 mg/1
• Pharm Classes: Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 70709-062-30

1 BLISTER PACK in 1 CARTON (70709-062-30) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

• Marketing Start Date: 2023-01-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details